Immunotherapy Is the Only Curative Treatment for Allergic Rhinitis
Allergen immunotherapy (either subcutaneous or sublingual) is the only disease-modifying intervention that can potentially cure allergic rhinitis rather than merely treating symptoms. 1, 2, 3
Understanding the Distinction: Treatment vs. Cure
All other interventions for allergic rhinitis—including intranasal corticosteroids, antihistamines, leukotriene receptor antagonists, and environmental controls—only provide symptomatic relief while the treatment continues. They do not alter the underlying immune response to allergens. Once these medications are stopped, symptoms typically return upon allergen exposure.
In contrast, immunotherapy works by gradually desensitizing the immune system to specific allergens, potentially providing:
- Persistent benefits after discontinuation of treatment 2
- Prevention of asthma development in patients with allergic rhinitis 2
- Long-term disease modification rather than temporary symptom control 3
When to Offer Immunotherapy
According to the American Academy of Otolaryngology guidelines, clinicians should offer or refer for immunotherapy (sublingual or subcutaneous) when patients have inadequate response to pharmacologic therapy with or without environmental controls 1.
More specifically, immunotherapy is indicated when patients have:
- Confirmed specific IgE to relevant allergens (via skin or blood testing) 2
- Poor response to medications and allergen avoidance 2
- Unacceptable adverse effects from medications 2
- Desire to avoid long-term pharmacotherapy 2
- Coexisting allergic rhinitis and asthma 2
Two Routes of Administration
Subcutaneous Immunotherapy (SCIT)
- Administered by injection in a medical setting
- Requires weekly visits during the initial 4-6 months 4
- Has decades of evidence supporting efficacy
- Carries potential for severe systemic reactions, requiring observation period after injections 4
- Can target multiple allergens simultaneously 4
Sublingual Immunotherapy (SLIT)
- Self-administered tablets or drops at home
- FDA-approved SLIT tablets include Oralair (mixed grass pollens), Grastek (Timothy grass), and Ragwitek (short ragweed) 5
- Reduced risk of systemic reactions compared to SCIT 4
- More convenient for patients but may have limited allergen options 4
The Treatment Algorithm
Step 1: Establish clinical diagnosis of allergic rhinitis based on symptoms (nasal congestion, rhinorrhea, itching, sneezing) and history of allergen exposure 1
Step 2: Initiate first-line pharmacotherapy:
- Intranasal corticosteroids for moderate-to-severe symptoms affecting quality of life 1
- Second-generation oral antihistamines for mild symptoms, particularly sneezing and itching 1
Step 3: If inadequate response to initial therapy, perform specific IgE testing (skin or blood) to identify causative allergens 1
Step 4: If symptoms remain inadequately controlled despite optimized pharmacotherapy and environmental controls, offer or refer for immunotherapy 1
Step 5: Continue immunotherapy for the recommended duration (typically 3-5 years for sustained benefit) 2
Critical Caveats
Immunotherapy is not immediate cure: It requires months to years of treatment before achieving maximal benefit. Patients need realistic expectations about the timeline.
Not all patients respond equally: While immunotherapy can be disease-modifying, individual responses vary. Some patients achieve complete remission, while others experience partial improvement.
Proper allergen identification is essential: Immunotherapy must target the specific allergens causing symptoms. This requires accurate diagnostic testing before initiating treatment 1, 2.
Safety considerations: SCIT carries risk of anaphylaxis and requires administration in settings equipped to manage severe allergic reactions 2. SLIT has a better safety profile but can still cause local reactions 4.
What About Other Interventions?
Environmental controls (removing pets, using air filtration, dust mite covers) may help reduce allergen exposure but do not cure the underlying allergic response 1. The evidence for their effectiveness is Grade B, and they function as adjunctive measures rather than curative treatments 5.
Surgical interventions like inferior turbinate reduction may help with nasal obstruction but do not address the allergic inflammation itself 1.
Acupuncture may be offered for patients interested in non-pharmacologic therapy, but there is insufficient evidence to determine if it provides disease-modifying effects 1.
Bottom Line
If your goal is to cure allergic rhinitis rather than continuously manage symptoms, immunotherapy is your only evidence-based option. It should be considered after confirming specific allergen sensitization and documenting inadequate response to conventional pharmacotherapy. The choice between subcutaneous and sublingual routes depends on allergen availability, patient preference, convenience factors, and cost considerations.